BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28501537)

  • 1. Effects of Exercise on Liver Fat and Metabolism in Alcohol Drinkers.
    Houghton D; Hallsworth K; Thoma C; Cassidy S; Hardy T; Heaps S; Hollingsworth KG; Taylor R; Day CP; Masson S; McPherson S; Anstee QM; Trenell MI
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1596-1603.e3. PubMed ID: 28501537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial.
    Houghton D; Thoma C; Hallsworth K; Cassidy S; Hardy T; Burt AD; Tiniakos D; Hollingsworth KG; Taylor R; Day CP; McPherson S; Anstee QM; Trenell MI
    Clin Gastroenterol Hepatol; 2017 Jan; 15(1):96-102.e3. PubMed ID: 27521509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exenatide decreases liver fat content and epicardial adipose tissue in patients with obesity and type 2 diabetes: a prospective randomized clinical trial using magnetic resonance imaging and spectroscopy.
    Dutour A; Abdesselam I; Ancel P; Kober F; Mrad G; Darmon P; Ronsin O; Pradel V; Lesavre N; Martin JC; Jacquier A; Lefur Y; Bernard M; Gaborit B
    Diabetes Obes Metab; 2016 Sep; 18(9):882-91. PubMed ID: 27106272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial.
    Hallsworth K; Thoma C; Hollingsworth KG; Cassidy S; Anstee QM; Day CP; Trenell MI
    Clin Sci (Lond); 2015 Dec; 129(12):1097-105. PubMed ID: 26265792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation.
    Bizino MB; Jazet IM; de Heer P; van Eyk HJ; Dekkers IA; Rensen PCN; Paiman EHM; Lamb HJ; Smit JW
    Diabetologia; 2020 Jan; 63(1):65-74. PubMed ID: 31690988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isocaloric Diets High in Animal or Plant Protein Reduce Liver Fat and Inflammation in Individuals With Type 2 Diabetes.
    Markova M; Pivovarova O; Hornemann S; Sucher S; Frahnow T; Wegner K; Machann J; Petzke KJ; Hierholzer J; Lichtinghagen R; Herder C; Carstensen-Kirberg M; Roden M; Rudovich N; Klaus S; Thomann R; Schneeweiss R; Rohn S; Pfeiffer AF
    Gastroenterology; 2017 Feb; 152(3):571-585.e8. PubMed ID: 27765690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial.
    Ross R; Janssen I; Dawson J; Kungl AM; Kuk JL; Wong SL; Nguyen-Duy TB; Lee S; Kilpatrick K; Hudson R
    Obes Res; 2004 May; 12(5):789-98. PubMed ID: 15166299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sweet Snacks Are Positively and Fruits and Vegetables Are Negatively Associated with Visceral or Liver Fat Content in Middle-Aged Men and Women.
    van Eekelen E; Geelen A; Alssema M; Lamb HJ; de Roos A; Rosendaal FR; de Mutsert R
    J Nutr; 2019 Feb; 149(2):304-313. PubMed ID: 30657914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate-Intensity Aerobic vs Resistance Exercise and Dietary Modification in Patients With Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial.
    Charatcharoenwitthaya P; Kuljiratitikal K; Aksornchanya O; Chaiyasoot K; Bandidniyamanon W; Charatcharoenwitthaya N
    Clin Transl Gastroenterol; 2021 Mar; 12(3):e00316. PubMed ID: 33939383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study.
    Kwak JH; Jun DW; Lee SM; Cho YK; Lee KN; Lee HL; Lee OY; Choi HS; Yoon BC
    Clin Nutr; 2018 Oct; 37(5):1550-1557. PubMed ID: 28918170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease.
    Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ
    Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents.
    van der Heijden GJ; Wang ZJ; Chu ZD; Sauer PJ; Haymond MW; Rodriguez LM; Sunehag AL
    Obesity (Silver Spring); 2010 Feb; 18(2):384-90. PubMed ID: 19696755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial.
    Zelber-Sagi S; Buch A; Yeshua H; Vaisman N; Webb M; Harari G; Kis O; Fliss-Isakov N; Izkhakov E; Halpern Z; Santo E; Oren R; Shibolet O
    World J Gastroenterol; 2014 Apr; 20(15):4382-92. PubMed ID: 24764677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of water-filtered infrared-A (wIRA) on reduction of local fat and body weight by physical exercise.
    Möckel F; Hoffmann G; Obermüller R; Drobnik W; Schmitz G
    Ger Med Sci; 2006 Jul; 4():Doc05. PubMed ID: 19675696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Metabolic and Hepatic Impact of Two Personalized Dietary Strategies in Subjects with Obesity and Nonalcoholic Fatty Liver Disease: The Fatty Liver in Obesity (FLiO) Randomized Controlled Trial.
    Marin-Alejandre BA; Abete I; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Quiroga J; Martinez-Echeverria A; Uriz-Otano JI; Huarte-Muniesa MP; Tur JA; Martinez JA; Zulet MA
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31652512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
    J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition and metabolic effects of a diet and exercise weight loss regimen on obese, HIV-infected women.
    Engelson ES; Agin D; Kenya S; Werber-Zion G; Luty B; Albu JB; Kotler DP
    Metabolism; 2006 Oct; 55(10):1327-36. PubMed ID: 16979403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effect of rapeseed oil or amaranth seed oil supplementation on weight loss, body composition, and changes in the metabolic profile of obese patients following 3-week body mass reduction program: a randomized clinical trial.
    Moszak M; Zawada A; Juchacz A; Grzymisławski M; Bogdański P
    Lipids Health Dis; 2020 Jun; 19(1):143. PubMed ID: 32563253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.